Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alzheimer Disease
Insulin and IGF-1 may have therapeutic roles in Alzheimer disease
October 27th, 2003
Insulin and insulin-like-growth-factor 1 (IGF-1) may have therapeutic roles in the treatment of Alzheimer disease. According to a study from Italy, "Aging is characterized by a significant decline of metabolic and hormonal functions, which often facilitates the onset of severe age-associated pathologies." "One outstanding example of this is the reported association of deranged signaling by insulin and insulin-like-growth-factor 1 (IGF-1) with Alzheimer's disease (AD)," said Laura Gasparini and Huaxi Xu at the Nicox Research Institute in Milan. "Recent compelling biological data reveal effects of insulin and IGF-1 on molecular and cellular mechanisms...
Source: Health & Medicine Week (2003-10-27)
|
